ReviewCancers2023

Evolution of the Targeted Therapy Landscape for Cholangiocarcinoma: Is Cholangiocarcinoma the 'NSCLC' of GI Oncology?

Amol Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.